News & Alerts
-
Oct- 2023 -2 October
FDA Denies Approval for Eli Lilly’s Eczema Treatment Drug
The U.S. Food and Drug Administration (FDA) has made a decision not to approve Eli Lilly’s drug, which was intended…
Read More » -
2 October
Viatris Announces Strategic Divestitures Totaling $3.6 Billion
On Sunday, pharmaceutical company Viatris announced that it has reached agreements to divest several of its business segments, totaling up…
Read More » -
2 October
Cigna and the U.S. Government Agree on a $172 Million Medicare Advantage Overbilling Settlement
Health insurer Cigna Group has recently reached a settlement with the United States government concerning allegations that it overcharged the…
Read More » -
2 October
Paxlovid’s Effectiveness Fades in Face of New Variants
A real-world study recently published in JAMA Open Network sheds light on the evolving effectiveness of Pfizer’s COVID-19 antiviral medication,…
Read More » -
2 October
Recognizing the Early Warning Signs of Uterine Cancer
What Is Uterine Cancer? Uterine cancer is a condition characterized by the presence of cancerous tumors within the uterus, a…
Read More » -
Sep- 2023 -30 September
Facts About The FBI Drug Bust In Louisville Kentucky
The FBI drug bust in Louisville, Kentucky, was a significant operation targeting a massive drug trafficking network. Here’s what you…
Read More » -
29 September
New Antibiotic, Ceftobiprole, Could Help Fight Resistant Staph Infections
By Cara Murez HealthDay Reporter New research shows that an antibiotic effective for bacterial pneumonia also appears to fight treatment-resistant…
Read More » -
29 September
Estrogen Could Be Key to Women’s Brain Health
By Cara Murez HealthDay Reporter Being exposed to more estrogen throughout life — or a longer reproductive life span —…
Read More » -
29 September
FDA Panel Says No to Experimental ALS Drug, NurOwn
By Cara Murez HealthDay Reporter An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against…
Read More » -
28 September
FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
By Cara Murez HealthDay Reporter Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will…
Read More »
